cGMP Capabilities The Center for Biocatalysis and Bioprocessing operates a state-of-the-art facility capable of cGMP production and Phase 1 clinical study protein manufacturing, presenting a strong opportunity to pitch early-stage biopharma partners seeking compliant microbial production.

End-to-End Services CBB offers comprehensive fermentation and protein purification with end-to-end process development to large-scale production, enabling sales conversations with biotech startups and established companies requiring seamless scale-up and turnkey outsourcing.

Academic Ties Strong ties to the University of Iowa and NIH-funded biotech training grants can be leveraged to position CBB as a trusted, academically backed partner for collaborative R&D programs and grant-funded development initiatives.

Regional Advantage Located in Iowa with a unique manufacturing footprint for protein products, CBB can appeal to regional biotech firms and Iowa-based programs seeking proximity, faster collaboration, and potential cost efficiencies in early manufacturing steps.

Growth Readiness With a revenue range in the tens of millions and an experienced full-time staff, CBB demonstrates scalability and reliability for mid-size collaborators, offering a compelling option for scale-out partnerships and long-term engagements.